Thrombomodulin-mediated catabolism of protein C by pleural mesothelial and vascular endothelial cells

Alexei V. Iakhiaev; Alireza R. Rezaie; Steven Idell

doi:10.1160/TH07-03-0223

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2007; 98(03): 627-634
DOI: 10.1160/TH07-03-0223

Endothelium and Vascular Development

Schattauer GmbH

Thrombomodulin-mediated catabolism of protein C by pleural mesothelial and vascular endothelial cells

Alexei V. Iakhiaev

¹The University of Texas Health Sciences Center at Tyler, Texas Lung Injury Institute, Tyler Texas, USA

,

Alireza R. Rezaie

²Department of Biochemistry and Molecular Biology, St. Louis University School of Medicine, St. Louis, Missouri, USA

,

Steven Idell

¹The University of Texas Health Sciences Center at Tyler, Texas Lung Injury Institute, Tyler Texas, USA

› Author Affiliations

Abstract

Summary

Pleural mesothelial and vascular endothelial cells express protein C (PC) pathway components including thrombomodulin (TM) and endothelial protein C receptor (EPCR) and activate PC by the thrombin-TM dependent mechanism.We used these cells as model systems to identify molecules involved in endocytosis and degradation of PC. We find that mesothelial and endothelial cells can bind, internalize and degrade PC.Addition of thrombin markedly induced degradation of PC by these cells in a TM-dependent fashion, implicating the involvement of the thrombin-TM complex in internalization and degradation of PC. This observation defines a novel function for the thrombin-TM complex as a degradation receptor for PC and suggests that PC is degraded concurrent with its activation.A PC Gla-domain mutant, which is unable to bind to the EPCR, was degraded by the cells to a lesser extent than wild-type PC, implicating the PC degradation concurrent with its activation. Consistent with the role of thrombin-TM complex as a degradation receptor, the catalytically inactive thrombin-S195A also induced PC degradation though to a lesser extent than wild-type thrombin.This suggests that generation of activated PC (APC) can contribute to accumulation of degradation products, but is not essential for the thrombin-induced degradation of PC. The thrombin-TMmediated degradation of PC by both cell types suggest a previously unrecognized mechanism, which can contribute to PC consumption.This mechanism may be pathophysiologically relevant and can contribute to an acquired PC deficiency in conditions characterized by sustained thrombin generation.

Keywords

Endocytosis - proteases - protein C/S pathway - thrombin - thrombomodulin

Full Text

References

References
1 Esmon CT. Inflammation and the activated protein C anticoagulant pathway. Semin Thromb Hemost 2006; 32 (Suppl. 01) 49-60.
2 Murakami K, Okajima K, Uchiba M. et al. Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production. Am J Physiol 1997; 272: L197-L202.
3 Grey ST, Tsuchida A, Hau H. et al. Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester. J Immunol 1994; 153: 3664-3672.
4 Hirose K, Okajima K, Taoka Y. et al. Activated protein C reduces the ischemia/reperfusion-induced spinal cord injury in rats by inhibiting neutrophil activation. Ann Surg 2000; 232: 272-280.
5 Feistritzer C, Sturn DH, Kaneider NC. et al. Endothelial protein C receptor-dependent inhibition of human eosinophil chemotaxis by protein C. J Allergy Clin Immunol 2003; 112: 375-381.
6 Finigan JH, Dudek SM, Singleton PA. et al. Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation. J Biol Chem 2005; 280: 17286-17293.
7 Zeng W, Matter WF, Yan SB. et al. Effect of drotrecogin alfa (activated) on human endothelial cell permeability and Rho kinase signaling. Crit Care Med 2004; 32 (Suppl. 05) S302-S308.
8 Esmon CT. The endothelial protein C receptor. Curr Opin Hematol 2006; 13: 382-385.
9 Abeyama K, Stern DM, Ito Y. et al. The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. J Clin Invest 2005; 115: 1267-1274.
10 Mosnier LO, Meijers JC, Bouma BN. Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin. Thromb Haemost 2001; 85: 5-11.
11 Maruyama I, Majerus PW. The turnover of thrombin- thrombomodulin complex in cultured human umbilical vein endothelial cells and A549 lung cancer cells. Endocytosis and degradation of thrombin. J Biol Chem 1985; 260: 15432-15438.
12 Maruyama I, Majerus PW. Protein C inhibits endocytosis of thrombin-thrombomodulin complexes in A549 lung cancer cells and human umbilical vein endothelial cells. Blood 1987; 69: 1481-1484.
13 Teasdale MS, Bird CH, Bird P. Internalization of the anticoagulant thrombomodulin is constitutive and does not require a signal in the cytoplasmic domain. Immunol Cell Biol 1994; 72: 480-488.
14 Conway EM, Pollefeyt S, Collen D. et al. The amino terminal lectin-like domain of thrombomodulin is required for constitutive endocytosis. Blood 1997; 89: 652-661.
15 Macias WL, Dhainaut JF, Yan SC. et al. Pharmacokinetic- pharmacodynamic analysis of drotrecogin alfa (activated) in patients with severe sepsis. Clin Pharmacol Ther 2002; 72: 391-402.
16 Berger Jr. H, Kirstein CG, Orthner CL. Pharmacokinetics of activated protein C in guinea pigs. Blood 1991; 77: 2174-2184.
17 Dhainaut JF, Laterre PF, LaRosa SP. et al. The clinical evaluation committee in a large multicenter phase 3 trial of drotrecogin alfa (activated) in patients with severe sepsis (PROWESS): role, methodology, and results. Crit Care Med 2003; 31: 2291-2301.
18 Li W, Zheng X, Gu J. et al. Overexpressing endothelial cell protein C receptor alters the hemostatic balance and protects mice from endotoxin. J Thromb Haemost 2005; 3: 1351-1359.
19 Bangalore N, Drohan WN, Orthner CL. High affinity binding sites for activated protein C and protein C on cultured human umbilical vein endothelial cells. Independent of protein S and distinct from known ligands. Thromb Haemost 1994; 72: 465-474.
20 Iakhiaev A, Idell S. Activation and degradation of protein C by primary rabbit pleural mesothelial cells. Lung 2006; 184: 81-88.
21 Rezaie AR, Esmon NL, Esmon CT. The high affinity calcium-binding site involved in protein C activation is outside the first epidermal growth factor homology domain. J Biol Chem 1992; 267: 11701-11704.
22 Wu Q, Tsiang M, Lentz SR. et al. Ligand specificity of human thrombomodulin. Equilibrium binding of human thrombin, meizothrombin, and factor Xa to recombinant thrombomodulin. J Biol Chem 1992; 267: 7083-7088.
23 Pei G, Baker K, Emfinger SM. et al. Expression, isolation, and characterization of an active site (serine 528----alanine) mutant of recombinant bovine prothrombin. J Biol Chem 1991; 266: 9598-9604.
24 Rezaie AR. Role of exosites 1 and 2 in thrombin reaction with plasminogen activator inhibitor-1 in the absence and presence of cofactors. Biochemistry 1999; 38: 14592-14599.
25 Smirnov MD, Safa O, Regan L. et al. A chimeric protein C containing the prothrombin Gla domain exhibits increased anticoagulant activity and altered phospholipid specificity. J Biol Chem 1998; 273: 9031-9040.
26 Esmon CT, Gu JM, Xu J. et al. Regulation and functions of the protein C anticoagulant pathway. Haematologica 1999; 84: 363-368.
27 Kisiel W, Davie E. Protein C. Methods Enzymol 1981; 80: 320-332.
28 Esmon CT, Owen WG. Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci USA 1981; 78: 2249-2252.
29 Fukudome K, Esmon CT. Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor. J Biol Chem 1994; 269: 26486-26491.
30 Fukudome K, Kurosawa S, Stearns-Kurosawa DJ. et al. The endothelial cell protein C receptor. Cell surface expression and direct ligand binding by the soluble receptor. J Biol Chem 1996; 271: 17491-17498.
31 Ye X, Fukudome K, Tsuneyoshi N. et al. The endothelial cell protein C receptor (EPCR) functions as a primary receptor for protein C activation on endothelial cells in arteries, veins, and capillaries. Biochem Biophys Res Commun 1999; 259: 671-677.
32 Ghosh S, Pendurthi UR, Esmon CT. et al. Endothelial cell protein C receptor acts as a cellular receptor for factor VIIa on endothelium. J Biol Chem 2007; prepub online.
33 Nishioka J, Ido M, Hayashi T. et al. The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va. Thromb Haemost 1996; 75: 275-282.
34 Lu G, Chhum S, Krishnaswamy S. The affinity of protein C for the thrombin.thrombomodulin complex is determined in a primary way by active site-dependent interactions. J Biol Chem 2005; 280: 15471-15478.
35 Stearns-Kurosawa DJ, Kurosawa S, Mollica JS. et al. The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. Proc Natl Acad Sci USA 1996; 93: 10212-10216.
36 Fukudome K, Esmon CT. Molecular cloning and expression of murine and bovine endothelial cell protein C/activated protein C receptor (EPCR). The structural and functional conservation in human, bovine, and murine EPCR. J Biol Chem 1995; 270: 5571-5577.
37 Regan LM, Mollica JS, Rezaie AR. et al. The interaction between the endothelial cell protein C receptor and protein C is dictated by the gamma-carboxyglutamic acid domain of protein C. J Biol Chem 1997; 272: 26279-26284.
38 Riewald M, Petrovan RJ, Donner A. et al. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 2002; 296: 1880-1882.
39 Riewald M, Petrovan RJ, Donner A. et al. Activated protein C signals through the thrombin receptor PAR1 in endothelial cells. J Endotoxin Res 2003; 9: 317-321.
40 Xie J, Qian L, Wang Y. et al. Role of the microtubule cytoskeleton in traffic of EGF through the lacrimal acinar cell endomembrane network. Exp Eye Res 2004; 78: 1093-1106.
41 Conway EM, Nowakowski B, Steiner-Mosonyi M. Thrombomodulin lacking the cytoplasmic domain efficiently internalizes thrombin via nonclathrin-coated, pit-mediated endocytosis. J Cell Physiol 1994; 158: 285-298.
42 Brisson C, Archipoff G, Hartmann ML. et al. Antibodies to thrombomodulin induce receptor-mediated endocytosis in human saphenous vein endothelial cells. Thromb Haemost 1992; 68: 737-743.
43 Dhainaut JF, Marin N, Mignon A. et al. Hepatic response to sepsis: interaction between coagulation and inflammatory processes. Crit Care Med 2001; 29 (Suppl. 07) S42-S47.
44 Li W, Zheng X, Gu JM. et al. Extraembryonic expression of EPCR is essential for embryonic viability. Blood 2005; 106: 2716-2722.